Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Group B Streptococcal disease in England (1998 - 2017): a population based observational study.

Kadambari S. et al, (2020), Clin Infect Dis

Mycobacterium tuberculosis-specific cytokine biomarkers to differentiate active TB and LTBI: A systematic review.

Sudbury EL. et al, (2020), J Infect

T cell assays differentiate clinical and subclinical SARS-CoV-2 infections from cross-reactive antiviral responses

Ogbe A. et al, (2020)

The Scientific and Ethical Feasibility of Immunity Passports

BROWN R. et al, (2020), The Lancet Infectious Diseases

A national consensus management pathway for Paediatric Inflammatory Multisystem Syndrome - Temporally associated with SARS-CoV-2 (PIMS-TS): The results of a national Delphi process

KNIGHT M. and ALLIN B., (2020), The Lancet Child and Adolescent Health

Principles of immunisation in children with solid organ transplant.

Kelgeri C. et al, (2020), Arch Dis Child

What defines an efficacious COVID-19 Vaccine? A review of the challenges assessing the clinical efficacy of vaccines against SARS-CoV-2

HODGSON S. et al, (2020), Lancet Infectious Diseases

Teaching and learning in ecology: a horizon scan of emerging challenges and solutions

Cooke J. et al, (2020), OIKOS

What time interval is needed between the administration of live attenuated vaccines?

Zimmermann P. et al, (2020), Arch Dis Child

Electronic data capture for large scale typhoid surveillance, household contact tracing, and health utilisation survey: Strategic Typhoid Alliance across Africa and Asia.

Thindwa D. et al, (2020), Wellcome open research, 5, 66 - 66

COVID-19 in children and adolescents in Europe: a multinational, multicentre cohort study

Götzinger F. et al, (2020), The Lancet Child & Adolescent Health, 4, 653 - 661

Elimination of typhoid: Possibility or pipe dream?

Purcell R. and Pollard AJ., (2020), J Paediatr Child Health, 56, 1340 - 1342

Encouraging Vaccination Ethically: How Can Pox Parties for Grannies and Vaccine-Preventable Diseases Be Avoided?

Vanderslott S., (2020), Am J Bioeth, 20, 68 - 70

Herd immunity and vaccination of children for COVID-19.

Velavan TP. et al, (2020), Int J Infect Dis, 98, 14 - 15

Mechanisms of response and resistance to AML therapies

Stoilova B. et al, (2020), Clinical Lymphoma, Myeloma & Leukemia, 20, S7 - S7

Results from ADVANCE: A phase I/II open-label non-randomised safety and efficacy study of the viral vectored ChAdOx1-MVA 5T4 (VTP-800) vaccine in combination with PD-1 checkpoint blockade in metastatic prostate cancer

Tuthill M. et al, (2020), ANNALS OF ONCOLOGY, 31, S543 - S543

Why the elderly appear to be more severely affected by COVID-19: The potential role of immunosenescence and CMV.

Kadambari S. et al, (2020), Rev Med Virol, 30

Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial

MUJADIDI YF., (2020)

The ‘Be on the TEAM’ Study (Teenagers Against Meningitis): Protocol for a controlled clinical trial evaluating the impact of 4CMenB or MenB-fHbp vaccination on the pharyngeal carriage of meningococci in adolescents

MAIDEN MCJ. et al, (2020), BMJ Open

Evaluation of the immunogenicity of prime-boost vaccination with the replication-deficient viral vectored COVID-19 vaccine candidate ChAdOx1 nCoV-19

Graham SP. et al, (2020), npj Vaccines

Load More

«
...
30
31
32
33
34
35
36
...
»

Include forthcoming?